Copyright 2002 eMediaMillWorks, Inc.
(f/k/a Federal
Document Clearing House, Inc.)
Federal Document Clearing House
Congressional Testimony
February 27, 2002 Wednesday
SECTION: CAPITOL HILL HEARING TESTIMONY
LENGTH: 2904 words
COMMITTEE:
SENATE SPECIAL AGING
HEADLINE:
SHORTAGE OF GERIATRIC CARE WORKERS AND TRAINING
TESTIMONY-BY: MICHAEL C. MARTIN, EXECUTIVE DIRECTOR
AFFILIATION: COMMISSION FOR CERTIFICATION IN GERIATRIC
PHARMACY
BODY: Statement of Michael C. Martin
Executive Director Commission for Certification in Geriatric Pharmacy (CCGP)
Mr. Chairman and Members of the Subcommittee,
My name is Michael
C. Martin and I am the Executive Director of the Commission for Certification in
Geriatric Pharmacy (CCGP). I would first like to commend the Members of this
committee for their support and work on legislation to assist seniors gain
access to improved care under Medicare, and to receive coverage for prescription
drugs, and to improve the quality of care in nursing facilities. In addition, I
would like to commend the Members' current interest in enacting federal
standards in assisted living facilities to improve quality of care.
CCGP
was invited by the Alliance for Aging Research to join their efforts to unite
the health professions in addressing the critical lack of geriatric-trained
health care professionals. Effectively caring for the elderly requires a
cooperative effort among the entire health care team. I am here today to discuss
the role of pharmacists in the interdisciplinary health care team and
specifically how Certified Geriatric Pharmacists (CGPs) can improve the
medication therapy management of seniors. I also will address areas in which
Congressional action can help to increase seniors' access to the expertise of
pharmacists. CCGP was founded in 1997 by the American Society of Consultant
Pharmacists (ASCP) to oversee the certification program in geriatric pharmacy
practice. ASCP is the international professional society representing senior
care pharmacists to provide medication therapy management and distribution
services to the senior population in nursing homes, assisted living facilities,
adult day care centers, retirement communities, and in the home. CCGP was
created to recognize and certify those pharmacists who have the special
knowledge, skills, and abilities to provide comprehensive pharmaceutical care to
the elderly. CCGP is a nonprofit corporation, autonomous from ASCP and with its
own governing Board of Commissioners. CCGP is responsible for establishing
certification standards, developing and administering the Certification
Examination in Geriatric Pharmacy, establishing eligibility criteria and program
policies, and issuing credentials. Candidates who successfully meet all program
requirements receive the designation "Certified Geriatric Pharmacist" or CGP.
To earn the CGP credential, pharmacists must demonstrate their expertise
through a rigorous, three-hour, psychometrically sound certification
examination. The 150-item multiple-choice CCGP exam is designed to assess
candidates' knowledge in three areas of practice: patient-specific activities
(34%), disease-specific activities (56%), and quality improvement/utilization
management activities (10%). The exam was developed by a 12-member committee of
geriatric pharmacy practitioners and educators under the guidance of CCGP
testing contractor Applied Measurement Professionals, a nationally prominent
testing company based in Lenexa, Kansas.
The CGP designation can help
ensure consumers that the pharmacist has special knowledge regarding the needs
of the senior population. CGPs can be effective in any setting to manage
seniors' medication regimens, including hospitals, the community, and long-term
care.
Currently, the CGP designation is the only designation that
recognizes the clinical expertise of these senior care pharmacists. This
designation has been recognized in the pharmacy practice acts of Arizona, North
Carolina, and Ohio. The CGP credential also has been recognized by the
Department of Veterans Affairs and is recognized in Australia and Canada. Yet,
only 720 out of nearly 200,000 pharmacists in the United States have received
the CGP designation. The reasons for this include the following:
-Lack
of federal recognition of pharmacists under the "Social Security Act" makes
pharmacists unable to bill Medicare and Medicaid for the clinical services that
they provide to manage patient medication therapy. To remedy this situation,
Senator Tim Johnson introduced S. 974, "The Medicare Pharmacists Services Act,"
that would recognize pharmacists under the "Social Security Act" and bill
Medicare for the services they provide.
-Most pharmacists who currently
specialize in senior care have acquired these skills on the job because until
recently the clinical literature lacked data regarding the effects of
medications on seniors, particularly the "old, old", age 85 and older, the
fastest growing segment of the population. Because of the effects of aging on
the body, seniors require very specific dosing adjustments to ensure that
toxicity leading to medication- related problems do not occur. However, until
recently and even now, clinical literature does not provide the necessary
information to appropriately provide care. As a result, many pharmacists are not
confident with their ability to manage the medication therapy of seniors much
less become certified in geriatric care. This committee should sponsor and
support legislation to require additional pharmaceutical research regarding the
effect of medications on the elderly.
-Lack of formal training in
geriatric pharmacy. Currently, schools of pharmacy often lack the availability
of curriculum in geriatric care. Students should be trained in schools of
pharmacy regarding the special needs of seniors. The lack of expertise among
current pharmacists leads to a vicious cycle of a lack of experts to teach
students to become geriatric pharmacists. Just like the need exists for schools
of pharmacy to develop curriculum to teach students, incentives need to be
provided for students to complete experiential rotations at hospitals, nursing
homes and other long-term care facilities, and in the community to provide for
the special needs of seniors.
-As this committee is patently aware, a
shortage of pharmacists currently exists in the United States. This means that
pharmacists often work 6-7 days a week leaving little time for preparation for a
rigorous exam to earn a credential in geriatrics. This could be relieved through
legislation proposed by Representative Jim McGovern in the House. This bill
would provide federal funding to schools of pharmacy to increase the number of
pharmacists to relieve the current shortage.
There have been promising
signs that interest in geriatrics, and the awareness of the impending crisis in
health care for older Americans, is increasing. There are countless advocacy
groups representing the aging, nearly all educational institutions address
geriatrics, and frequent reports in the media on health issues among older
Americans reflect the growing importance of this issue. But it's clear that the
rate at which medical schools, pharmacy schools, nursing, and other health care
disciplines are producing individuals who have the motivation and expertise to
manage this complex population continues to lag behind its staggering growth.
There are a number of reason why geriatrics has not been a popular
specialty for health care providers. These include: the complexity of care for
older patients; an unfortunate lack of interest in individuals approaching the
end of their lives; and, most significantly, a lack of payment mechanisms that
address the unique medical approach required to effectively manage older
patients.
This lack of emphasis on the special medication needs of
seniors must end. Currently, medication-related problems cost the United States
health care system more than $200 billion per year (approximately 60 percent can
be attributed to the geriatric population) and are the fifth leading cause of
death in the United States. These medication related problems including adverse
drug reactions, improper dosing (over or under prescribing), multiple
medications for the same indication, and drug induced hospitalizations are often
preventable. In fact, a 1997 study published in the Archives of Internal
Medicine found that in nursing facilities, interventions by consultant
pharmacists reduced the number of patients who experienced a medication related
problem by almost 50 percent and saved $3.6 billion per year in these settings.
The need for pharmacists' intervention, particularly CGPs, will become
more acute as medications become a more integral part of medical therapy. While
medications may replace other more invasive medical interventions such as
surgery, they are sophisticated technology that require careful monitoring by
highly trained professionals. This need will increase when Medicare finally
provides seniors with a drug benefit. Already, seniors age 65 and over consume
nearly one-third of the one billion prescriptions dispensed each year. The
percentage of prescription products consumed by seniors will continue to grow as
millions of baby boomers age and require medications for chronic conditions. In
addition, the number of prescriptions dispensed continually increases each year
and this number will also increase.
To assist pharmacy and the geriatric
population gain access to the types of services necessary to ensure the highest
quality of care; I urge the committee and your colleagues in Congress to take
the following steps:
-Pass a
Medicare prescription drug
benefit that includes pharmacy for pharmacist medication therapy management
services. This legislation should recognize the CGP designation for pharmacists
who participate in medication therapy management.
-Pass legislation to
recognize pharmacists under the "Social Security Act" to allow pharmacists to be
paid directly for the clinical services they provide.
-Pass legislation
to provide funding for additional pharmacists to relieve the shortage and to
provide incentives to bolster geriatric curriculum in schools of pharmacy.
-Provide funding for pharmacist residency programs in geriatric care.
-Preserve the federal nursing facility standards and the requirement
that consultant pharmacists provide drug regimen review to reduce medication
related problems.
Much of the tragic waste of health care resources, and
even more tragic consequences to our nation's seniors is preventable. In
Medicare and Medicaid certified nursing facilities, for example, federal
standards require that a consultant pharmacist review every resident's
prescribed drug regimen at least once a month, and report concerns and
recommendations to physicians. These professional services provided by the
pharmacist save millions every year by preventing or resolving
medication-related problems. Every Medicare and Medicaid-eligible senior should
be afforded, as a basic protection, the kind of pharmacist-conducted medication
supervision that protects today's nursing facility residents.
When
nursing facility reforms, including requirements for monthly drug regimen
reviews conducted by a consultant pharmacy, were enacted in 1974, the typical
nursing home resident was indistinguishable from today's assisted living
resident. The health status and medication use patterns of seniors who reside in
assisted living facilities and in the community are nearly identical to those of
nursing facility residents.
Thirty years ago, many individuals were
placed in nursing homes because of incontinence or other disability that today
can be managed by drug therapy or improved support systems. But the kind of
abuses, poor supervision, and inadequate care that led to federal nursing home
reforms are already being seen in the growing assisted living environment.
There are no federal standards protecting residents of assisted living
facilities, nor for Medicare- or Medicaid-eligible seniors in a variety of other
settings. And, of course, while the Medicare program does not pay for outpatient
prescription drugs for community dwelling seniors, it pays billions for the
health consequences of medication-related problems.
Pharmacists save
lives. They can save more, as well as millions of health care dollars, if
mechanisms are in place that pay qualified pharmacists for their professional
medication consulting services, either as part of compensation for dispensing
pharmaceuticals, or as a separate clinical service.
Certified Geriatric
Pharmacists, the experts in monitoring pharmacotherapy in seniors, are uniquely
qualified to identify individuals who are at high risk for medication-related
problems, or to identify and resolve health problems that are not being
recognized as drug-related. Pharmacists act as patient advocates on behalf of
the seniors they serve, working with physicians, nurses, caregivers, family
members, and other health professionals to protect seniors from drug related
problems and improve their quality of life.
Certified Geriatric
Pharmacists are particularly aware that seniors, such as those living in nursing
facilities, are often forgotten. Many nursing facility residents have no family,
or receive visitors only rarely. They may be difficult to manage and hard to
communicate with, but geriatricians, pharmacists, nurses, and other's dedicated
to geriatric medicine serve as their advocates, and recognize their value.
If we continue to neglect the health care needs of seniors, the health
care system will face collapse under the incredible cost of tens of millions of
seniors living into their 70s, their 80s, their 90s, and beyond. Care for the
elderly requires looking at the whole patient, not just a disease or an organ
system, to anticipate the enormous health risks facing nearly every senior. It
is a focus not on one ailment, or even on the management of symptoms, but of
preserving the patient's ability to live as independently as possible, to allow
them to continue, as long as possible, to perform their activities of daily
living and to preserve their functionality.
Yes, seniors want to be free
of pain, and they want to manage their symptoms and chronic illness. But what
seniors want most of all is to preserve their independence, to avoid being a
burden to others, to be treated with respect and consideration. In seniors, drug
related problems cannot be viewed in isolation, nor even can a review of all the
drugs a geriatric patient consumes yield a complete picture of the risk for
drug-related problems.
For example, the consensus of opinion among
researchers and clinicians is that an elderly individual who takes nine or more
medications should be considered at risk for medication related problems. That's
a conclusion you could draw without any additional information about the
patient. But a senior taking only four different prescribed medications who also
has a history of falls or incontinence is also considered to be at risk for
medication problems, according to a consensus drawn from evidence- based
research.
Why? Because a potentially catastrophic event for a senior,
such as a fall, is actually a medication-related problem. Health care providers
who are not specialists in the care of the elderly may not recognize it as such,
but medications that cause dizziness, or that make a senior get up to go to the
bathroom in the middle of the night and suffer a fall and a broken hip,
constitute a medication-related problem.
As a result, we pay for
emergency room visits, hip replacement surgery, physical therapy, repeat visits
to the hospital, treatment for stroke, and nursing home care. That's how a
relatively healthy senior, with one medication-related event, can go from
independence to tragedy. We don't pay for the relatively simple measures that
could have prevented all that suffering, and all that expense.
Identifying these kinds of risk factors requires health care specialists
that look at the whole patient, and who understands the extraordinary complexity
of drug therapy in a patient with altered metabolism, physical disabilities,
multiple chronic illness, limited caregiver support, neurological and
psychological problems, and myriad other factors.
Effective care of
seniors requires an interdisciplinary approach, including pharmacists,
physicians, nurses, physical therapists, nutritionists, care managers, and
others. The efforts of these professionals to prevent life-threatening, costly
health care problems among the elderly must be appropriately compensated. This
is cost-effective care that simply doesn't fit with our current thinking about
payment for medical services.
We must reform the way our nation
approaches medical care for seniors. Effective health care for seniors requires
a coordinated assessment and case management provided by an interdisciplinary
team focused on the patient's overall well-being. Public and private health care
systems simply do not pay for that kind of care. Instead, they pay for expensive
tests and treatments, but not for the kind of care needed to identify the
at-risk elderly and protect them from potentially life threatening medical
problems.
I would like to commend the members of the Senate Special
Committee on Aging for the leadership role it has played in raising our nation's
awareness of the health care needs of the elderly, and in taking insightful
initiatives to address their unmet needs. Seniors are unique patients who
require and deserve the care of unique pharmacists.
Again, thank you
very much for this opportunity to appear before you to address this important
national issue and we look forward to working with you on this issue in the
future.
LOAD-DATE: February 27, 2002